About Us 2021
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Institute for Information Law Self-Assessment Report (2009–2015)
Institute for Information Law Self-Assessment Report (2009–2015) ivir self-assessment report (2009–2015) Amsterdam, March 2016 Institute for Information Law (IViR) Vendelstraat 7 1012 XX Amsterdam The Netherlands Website: http://ivir.nl/ Phone: + 31 (0)20 525 3406 Email: [email protected] Layout: Suzanne Bakkum 2 ivir self-assessment report (2009–2015) Table of Contents Section I Description of the research group and its research program 1 1.1 Organization 1 Title 1 General description 1 Composition 1 Organization 1 Financing 2 1.2 Overall strategy 2 Mission and vision 2 Paradigm and research methods 2 Research profile and strategy 3 1.3 Past and future targets 4 1.4 Applicable performance indicators 5 Research quality 6 Relevance to society 6 1.5 Results obtained 7 Societal relevance 11 1.6 Own assessment of quality, relevance and viability 14 Research quality 15 Relevance to society 15 Viability 15 Previous external assessments 15 1.7 Relevant environmental factors and developments 16 1.8 SWOT analysis and benchmark/positioning 17 Benchmarks 18 Section II Appendices 19 2.1 Table describing the composition of the research unit 19 2.2 Table reflecting the publications output 20 2.3 Table indicating the research unit’s financing structure 21 2.4 Five most important scientific publications 21 2.5 Five most important societal publications 22 2.6 Previous external assessment reports 23 2.7 Awards and individual research grants 31 Prizes, honors and awards 31 Individual research grants 32 2.8 Publications output 33 2.9 Reports and studies of societal -
Innovation Hub for Life Sciences
explore! page and and page Turn the the Turn Sciences Hub for Life Life for Hub is the the is Innovation Innovation Bio Science Park Park Science Bio Why Leiden Leiden Why 10 Reasons 10 Leiden Bio Science Park, the Innovation Hub for Life Sciences The leading Dutch Life Sciences & Health Innovation Hub in West Holland The park is situated in the West Holland region and is centrally located between Amsterdam and Rotterdam, in the economic heart of the Netherlands. With the upcoming relocation of the European Medicines Agency (EMA) in the surrounding area, it is time to seize the moment and settle in the fastest growing science park. Turnkey offices, dedicated laboratories and 300,000 square metres of green fields are at your disposal. Interested in setting up or expanding your activities at the Leiden Bio Science Park? Please contact us at: Leiden Bio Science Park BioPartner Center 2 2333 CH Leiden The Netherlands T: +31 (0) 71 5247555 E: offi[email protected] lbsp.nl lifesciencesinwestholland.nl 10 Reasons why Leiden Bio Science Park is the Innovation Hub for Life Sciences The Leiden Bio Science Park is the largest and most mature life sciences cluster in the Netherlands. Located at the park are over a 100 dedicated biomedical companies, including several multinationals such as Johnson & Johnson, Astellas and Galápagos. The park has the highest number of bioscience start-ups in the Netherlands providing a dynamic environment for the development of exciting novel therapeutics. This combination positions Leiden as a significant international ‘R&D hub’. INNOVATION 1 Among top 5 European Science Parks Leiden Bio Science Park is the number 1 Life Sciences & Health hotspot in The Netherlands and one of the most important clusters within Europe 2 10 educational institutes, a highly educated life sciences labor force Leiden Bio Science Park has a wide range of research and educational institutions, from top academic institutes, to PhDs & postdocs, and vocational level education. -
Opens Innovation Hub in Leiden Bio Science Park
GRÜNENTHAL GROUP Press Release Grünenthal's Innovative Medicines Unit (IMU) opens its first Innovation Hub to further strengthen the company’s networked Research and Development approach • The IMU – Leiden Hub will serve as Grünenthal’s European center for Open Innovation • Integration in scientific community of Leiden Bio Science Park, the Netherlands, enables easier access and close collaboration with leading scientists and institutions • At Leiden Bio Science Park, about 17,000 employees in biomedical companies, research institutions and hospitals are dedicated to the development of innovative drugs and solutions to support patients Aachen, Germany, and Leiden, the Netherlands, January 6, 2016 – The Grünenthal Group, an international, family-owned pharmaceutical company, announced today the opening of an Innovation Hub as an expansion of its Innovative Medicines Unit. The Hub will be located in Leiden, the Netherlands, and be embedded in the Leiden Bio Science Park, the largest cluster of biotech and pharmaceutical companies in the Netherlands and one of the five most successful science parks in Europe. The IMU – Leiden Hub will enable Grünenthal to engage even more strongly in networked research and development by building strong alliances and partnerships with academia, the biotech community and innovative service providers. The parties involved strive to jointly find solutions for patients suffering from illnesses with high unmet medical need and to bring these solutions faster to the patients by improving the “bench to bedside”-approach. Entrepreneurial and networked approach to R&D "We are excited to open the first hub of our Innovative Medicines Unit", says Dr. Klaus-Dieter Langner, Chief Scientific Officer of Grünenthal. -
European Life Science Ceo Forum
WELCOME SPONSORS SPEAKERS PRESENTING COMPANIES 3rd Annual EUROPEAN LIFE SCIENCE CEO FORUM for PARTNERING & INVESTING AWARDS ORGANISATIONS PARTNERING 11-12 February 2010 ConventionPoint, Zurich, Switzerland Conference Guide REGIONAL PARTNERS ORGANISERS EUROPEAN LIFE SCIENCE CEO FORUM www.sachsforum.com WELCOME SPONSORS next Welcome Sachs Associates are delighted to welcome you to the: SPEAKERS PRESENTING COMPANIES 3rd Annual European Life Science CEO Forum for Partnering & Investing 11-12 February 2010 ConventionPoint, Zurich, Switzerland Sachs Associates are delighted to welcome you to the 3rd Annual European Life Science CEO Forum for Partnering & Investing. Following its success from previous years, the forum once again provides access to an exciting cross-section of venture-funded and small-cap companies with leading investors and pharmas. This exclusive and transactional event complements our Annual Biotech in Europe Investor Forum, held later in the year, but with added focus on Partnering & the pharmaceutical industry, feature presentations from Big Pharma representatives demonstrating their AWARDS ORGANISATIONS PARTNERING current and future partnering strategies through thought-provoking case studies. This year’s programme features a series of panels and presentations from leading investment, pharmaceutical and biotech companies, highlighting the current issues surrounding the evolving M&A market, Vaccines, Medtech Investment and includes special keynote speeches, providing an expert outlook on Europe’s Biotech industry. In addition, the event holds more than 50 company presentations from an exciting and diverse range of publicly listed and private life science companies, looking to raise fi nance and/or fi nd partners. This year’s DyoDelta Life Science Innovation Awards takes place in the evening of the 11th February and the awards recognise exceptional performance in key categories of partnering and fi nancing within the industry. -
Preliminary Programme of the International E-Conference “EU Values, Diversity and Intercultural Dialogue: Enhancing the Debate” 21-23 April 2021
JEAN MONNET PROJECT EU VADIS – HELLENIC ASSOCIATION FOR EUROPEAN LAW UNIVERSITY OF MACEDONIA, GREECE ATHENS, GREECE Last update: 16/4/2021 Preliminary Programme of the international e-Conference “EU Values, Diversity and Intercultural Dialogue: Enhancing the debate” 21-23 April 2021 WEDNESDAY, April 21st 2021 11:00 - 11:30 Athens time Welcome – Despoina ANAGNOSTOPOULOU, Associate Professor, Department of International and European Studies, Academic Coordinator of the Jean Monnet Project EUVadis, University of Macedonia, Thessaloniki, Greece Opening remarks Professor Evgenia ALEXANDROPOULOU, Vice Rector, University of Macedonia, Thessaloniki, Greece Athanasios ZERVAS, Dean of the School of Social Sciences, Humanities and Arts, University of Macedonia, Thessaloniki, Greece Ilias KOUSKOUVELIS, Head of the Department of International and European Studies, University of Macedonia, Thessaloniki, Greece Margaritis SCHINAS, Vice-President of the European Commission, Commissioner for Promoting our European Way of Life (recorded message) Costas TSOUTSOPLIDES, Head of the European Parliament Liaison Office in Athens, Greece Page 1 of 15 Website: https://jmpeuvadis.uom.gr E-mail: [email protected] Facebook Page: @JMP.EUVaDis Tel: +30 2310 891442 Opening Session 11:30 - 13:00 Athens time Chair: Vassilios SKOURIS, f. President and Judge of the European Court of Justice, President of the Governing Board of the Hellenic Association for the European Law (HAEL), President of the Governing Board of the Centre of International and European -
Jaarverslag 2012 Copy 8 Universiteit Leiden
Jaarverslag 2012 Inhoud Woord vooraf .................................................................... 5 Bijlagen A. Faculteiten, graduate schools, instituten en 1. Profiel, missie en strategie ...................................... 6 profielthema’s .............................................................. 125 1.1 Bericht van de Raad van Toezicht ............................ 6 B. Kerncijfers ................................................................... 127 1.2 Profiel, missie en strategie ........................................ 9 C. Opleidingenaanbod .................................................... 145 1.3 Universitair bestuur en organigram ........................ 13 D. Persoonsgebonden subsidies ...................................... 149 1.4 Universiteitsraad – medezeggenschapsraad ............ 15 E. Onderscheidingen en eredoctoraten .......................... 153 F. Hoogleraren: benoemingen en oraties ....................... 155 2. Onderwijs ................................................................. 16 G. Promoties .................................................................... 161 2.1 Onderwijsprofiel ...................................................... 16 H. Besturen ....................................................................... 177 2.2 Bachelor .................................................................... 16 I. Afkortingen ................................................................. 181 2.3 Master ....................................................................... 18 2.4 Graduate -
Hollandbio Business Solutions Member-To-Member Guide
HollandBIO Business Solutions Member-to-Member Guide 2017 2 HollandBIO Business Solutions 3 Preface Though small in surface area, the Netherlands definitely is a major player in life sciences. The Dutch sector owes its success to an entrepreneurial spirit, a great scientific backbone, a remarkable talent to get stuff organized and a natural ability to cooperate. HollandBIO is the Dutch biotech industry association. We actively look after the sector’s interests and support a strong, more than willing to show starters the national and international network. ropes! In addition, the range of HollandBIO’s activities include advocacy, professional services tuned to the needs networking, national and international of life sciences companies is rapidly representation, as well as our HollandBIO increasing. Business Solutions: a range of services dedicated to supporting start-ups and This booklet proudly presents the 2017 SMEs. HollandBIO member companies. It is part of our Member-to-Member (M2M) HollandBIO strives to enable program, which helps biotech companies entrepreneurs to keep their eyes on the to build on the sector’s combined ball: to build a successful company knowledge and to gain insight in existing enabling society to profit from innovative services. And, HollandBIO members and valuable biotech products. Running a exclusively benefit from a number of company in life sciences is challenging. It attractive promotions! requires dedication, persistence and courage. The biotech world is highly Have a look what’s on offer! specialized and advice from biotech pioneers as well as professional service providers is essential to succeed. Annemiek Verkamman Fortunately, seasoned entrepreneurs are Managing Director HollandBIO Member-to-Member Guide 4 Content The HollandBIO members are listed in alphabetical order. -
Business & Investment Opportunities in West Holland
Business & Investment opportunities in West Holland Chris van Voorden Director Foreign Investments In this presentation 1 Content . About InnovationQuarter . The West Holland region . Strong economic sectors . Opportunities / invest & innovate in West Holland 2 About InnovationQuarter / invest & innovate in West Holland About InnovationQuarter 3 Shareholders . the Dutch Ministry of Economic Affairs and the Province of South-Holland . the municipalities of Delft, The Hague, Dordrecht, Leiden, Rotterdam & Westland . the three universities of Delft (University of Technology), Leiden & Erasmus Rotterdam and the two academic medical centers Erasmus MC & LUMC. / invest & innovate in West Holland Our tasks 4 We fund cutting edge and fast growing businesses with our own investment fund (InnovationQuarter Capital). We organize co-operation between innovative companies, knowledge institutions and government (InnovationQuarter Business Development). We assist foreign enterprises setting up their business in West Holland (InnovationQuarter Foreign Investments). / invest & innovate in West Holland 5 About the West Holland region / invest & innovate in West Holland About West-Holland 6 Facts about our region - 3.5 million inhabitants - 21 % of total GDP in The Netherlands - Port of Rotterdam, largest port in Europe - Three internationally highly rated universities - Many technological top institutes (TNO, ESA, Deltares) / invest & innovate in West Holland Key sectors in West Holland region 7 Clean Tech Life Safety & Sciences & Security Health IQ HortiCulture High Tech / Smart Industry / invest & innovate in West Holland About our region High Density of High Tech Systems & Materials 8 / invest & innovatie in West Holland 9 Life Sciences & Health / invest & innovate in West Holland InnovationQuarter 1 Life Sciences & Health 0 10 Medical Delta: West Holland LSH cluster . High Level business locations: . -
Life Sciences Cluster Report
Life Sciences Cluster Report Global | 2014 Global competition heats up as small and mid-tier companies dictate demand • Innovative leadership is recalibrating as emerging countries, particularly those in Asia, report impressive growth figures in patent applications, R&D funding, labor productivity and science degrees. • The demand environment has shifted from one driven by Big Pharma companies to one where mid-tier companies and specialty players are experiencing overnight growth and highly variable needs in response to promising products and treatments. JLL | Life Sciences Cluster Report | 2014 A message from Roger Humphrey Beyond the shifting demand among big and small industry players, we have also noticed the Roger Humphrey is the Executive Managing Director and changes in geographic activity and demand continuing over the past year. The United States and practice lead for the life sciences business at JLL. Roger Europe have enjoyed deep-seated roots as the leaders of high-value aspects of the development guides a team of more than 1,400 professionals dedicated to cycle, like new product research & development (R&D). In recent years, however, innovative developing customized solutions that help pharmaceutical leadership is recalibrating, with many developing nations making moves to grow their domestic and biotech companies reduce costs and boost productivity capabilities for innovation. Asian countries, led by Japan, Korea and China, have dramatically throughout their real estate and facilities portfolios. increased their share of patent applications and the number of doctorate and other higher education degrees awarded in science and engineering fields. The United States remains the dominant His background includes over 29 years in Commercial Real contributor of life sciences patent applications by a significant margin, but its year-on-year growth Estate and Facilities Management. -
2018 Press Information
2018 PRESS INFORMATION Contents 1 General 4 2 Leiden - Key to Discovery 5 3 History 6 4 Waterways 7 5 Museums 8 6 Leiden's Inner City 11 7 Rembrandt van Rijn 12 8 Theatre 13 9 Monuments 14 10 Walks 18 11 Shopping 20 12 Music 21 13 Restaurants 22 14 Accessibility 23 15 Hotels 24 16 Leiden Congrescentrum (Conference Centre) 25 17 Leiden is a Significant Knowledge Centre 26 18 Did you know… 28 19 Leiden Tourist Information Centre 29 "Leiden - Key to Discovery" Leiden Marketing aims to emphasise the culture and knowledge pillars in order to present the city as an ideal destination for Dutch tourists, holiday makers and national or international knowledge workers looking for quality. Note to the Editor For further information: Mincke Pijpers Leiden Marketing Communications & PR Phone: 0031 71 51 60 993 Email: [email protected] Website: www.visitleiden.nl/en/contact/press Facebook: www.facebook.com/OntdekLeiden Twitter: www.twitter.com/OntdekLeiden Images Leiden Marketing has an online image bank from which you may download images copyright-free for editorial support of Leiden. Please do sent a mail to Mincke Pijpers for access to this gallery. 1 General Leiden is situated in the county of South-Holland, between The Hague and Amsterdam. The distance between Leiden and the North Sea coast is 12 kilometres. The historic compact city, which has lots of attractions within walking distance, links the Bulb Region and the Green Heart. Facts and Figures • 122,000 inhabitants • 30,000 students • 200 restaurants • 60 bars • 22 hotels • 3000 hotel -
Encyclopedia of Law and Economics
Encyclopedia of Law and Economics Alain Marciano Giovanni Battista Ramello Editors Encyclopedia of Law and Economics With 146 Figures and 50 Tables Editors Alain Marciano Giovanni Battista Ramello MRE and University of Montpellier DiGSPES Montpellier, France University of Eastern Piedmont Alessandria, Italy Faculté d’Economie Université de Montpellier and IEL LAMETA-UMR CNRS Torino, Italy Montpellier, France ISBN 978-1-4614-7752-5 ISBN 978-1-4614-7753-2 (eBook) ISBN 978-1-4614-7754-9 (print and electronic bundle) https://doi.org/10.1007/978-1-4614-7753-2 Library of Congress Control Number: 2019930845 © Springer Science+Business Media, LLC, part of Springer Nature 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. -
The EU at a Crossroads
The EU at a Crossroads The EU at a Crossroads: Challenges and Perspectives Edited by Despina Anagnostopoulou, Ioannis Papadopoulos and Lina Papadopoulou The EU at a Crossroads: Challenges and Perspectives Edited by Despina Anagnostopoulou, Ioannis Papadopoulos, and Lina Papadopoulou This book first published 2016 Cambridge Scholars Publishing Lady Stephenson Library, Newcastle upon Tyne, NE6 2PA, UK British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Copyright © 2016 by Despina Anagnostopoulou, Ioannis Papadopoulos, Lina Papadopoulou and contributors All rights for this book reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the copyright owner. ISBN (10): 1-4438-9929-1 ISBN (13): 978-1-4438-9929-1 This project of Doctoral Colloquium has been funded with the support from the European Commission. This communication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. TABLE OF CONTENTS Preface and Acknowledgements .............................................................. ix The Co-Editors: Despina Anagnostopoulou, Associate Professor, Department of International and European Studies, Jean Monnet Chair, University of Macedonia, Thessaloniki, Greece Ioannis Papadopoulos, Assistant Professor, Department of International and European Studies, University of Macedonia, Thessaloniki, Greece Visiting Professor at the University Panthéon-Sorbonne Paris 1 and Sciences Po, Paris, France Lina Papadopoulou, Associate Professor, Law School, Jean Monnet Chair, Aristotle University of Thessaloniki, Thessaloniki, Greece Structure of the Book .............................................................................. xii The Co-Editors: D.